share_log

北大医药(000788.SZ):盐酸丁螺环酮片获批增加10mg规格

PKU HealthCare Corp. (000788.SZ): The approval has been granted for the addition of a 10mg specification for Buprenorphine Hydrochloride Tablets.

Gelonghui Finance ·  Dec 23, 2024 03:36

On December 23, Gelonghui reported that PKU HealthCare Corp. (000788.SZ) announced that it recently received the "Drug Supplement Application Approval Notice" issued by the National Medical Products Administration. The pharmaceutical name is Buprenorphine Hydrochloride Tablets, and the administration approved the supplementary application for an additional 10mg specification, issuing a drug approval number. This product has passed the consistency evaluation of quality and efficacy for generic pharmaceuticals.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment